The impact of kidney function on the efficacy and safety of pazopanib in metastatic renal cell carcinoma (mRCC) patients: CORE-UR0-01 study / Vitale, Mg; Masini, C; Procopio, G; De Giorgi, U; Buti, S; Rossetti, S; Iacovelli, R; Mucciarini, C; Cosmai, L; Vignani, F; Prati, G; Scagliarini, S; Berselli, A; Pinto, C. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 35:Supplement(2017). [10.1200/JCO.2017.35.15_suppl.e16063]

The impact of kidney function on the efficacy and safety of pazopanib in metastatic renal cell carcinoma (mRCC) patients: CORE-UR0-01 study

Buti S;
2017

The impact of kidney function on the efficacy and safety of pazopanib in metastatic renal cell carcinoma (mRCC) patients: CORE-UR0-01 study / Vitale, Mg; Masini, C; Procopio, G; De Giorgi, U; Buti, S; Rossetti, S; Iacovelli, R; Mucciarini, C; Cosmai, L; Vignani, F; Prati, G; Scagliarini, S; Berselli, A; Pinto, C. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 35:Supplement(2017). [10.1200/JCO.2017.35.15_suppl.e16063]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2906936
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact